188 related articles for article (PubMed ID: 10859937)
1. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
[TBL] [Abstract][Full Text] [Related]
2. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
3. [Genetic polymorphisms on drug metabolizing enzymes in relation to anti-cancer drug effectiveness].
Ozawa S
Rinsho Byori; 2003 Feb; 51(2):168-73. PubMed ID: 12690635
[TBL] [Abstract][Full Text] [Related]
4. Xenobiotic-metabolizing enzymes and cancer risk: correspondence between genotype and phenotype.
Pelkonen O; Raunio H; Rautio A; Lang M
IARC Sci Publ; 1999; (148):77-88. PubMed ID: 10493250
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetics and its importance in the clinical].
Lares-Asseff I; Trujillo-Jiménez F
Gac Med Mex; 2001; 137(3):227-36. PubMed ID: 11432091
[TBL] [Abstract][Full Text] [Related]
6. Species differences in the response of liver drug-metabolizing enzymes to (S)-4-O-tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric acid (EMD 392949) in vivo and in vitro.
Richert L; Tuschl G; Viollon-Abadie C; Blanchard N; Bonet A; Heyd B; Halkic N; Wimmer E; Dolgos H; Mueller SO
Drug Metab Dispos; 2008 Apr; 36(4):702-14. PubMed ID: 18216275
[TBL] [Abstract][Full Text] [Related]
7. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
Nebert DW; McKinnon RA; Puga A
DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
[TBL] [Abstract][Full Text] [Related]
8. Inter-individual Variability in Activity of the Major Drug Metabolizing Enzymes in Liver Homogenates of 20 Individuals.
den Braver-Sewradj SP; den Braver MW; van Dijk M; Zhang Y; Dekker SJ; Wijaya L; Vermeulen NPE; Richert L; Commandeur JNM; Vos JC
Curr Drug Metab; 2018; 19(4):370-381. PubMed ID: 29318967
[TBL] [Abstract][Full Text] [Related]
9. Cytochromes P450: decision-making tools for personalized therapeutics.
Murray M; Petrovic N
Curr Opin Mol Ther; 2006 Dec; 8(6):480-6. PubMed ID: 17243482
[TBL] [Abstract][Full Text] [Related]
10. Genetic basis of toxic reactions to drugs and chemicals.
Cascorbi I
Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
[TBL] [Abstract][Full Text] [Related]
11. Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes.
Frye RF; Matzke GR; Adedoyin A; Porter JA; Branch RA
Clin Pharmacol Ther; 1997 Oct; 62(4):365-76. PubMed ID: 9357387
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of antipsychoatics.
Ozaki N
Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
[TBL] [Abstract][Full Text] [Related]
13. Effects of hepatic drug-metabolizing enzyme induction on clinical pathology parameters in animals and man.
Ennulat D; Walker D; Clemo F; Magid-Slav M; Ledieu D; Graham M; Botts S; Boone L
Toxicol Pathol; 2010 Aug; 38(5):810-28. PubMed ID: 20585144
[TBL] [Abstract][Full Text] [Related]
14. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
Mathijssen RH; van Schaik RH
Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
16. [Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].
Yamazoe Y; Nagata K
Nihon Rinsho; 2001 Aug; 59(8):1614-23. PubMed ID: 11519169
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics and human cancer.
Nebert DW
IARC Sci Publ; 1982; (39):365-80. PubMed ID: 7152614
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles of drug-metabolizing enzymes (DMEs) in rat liver during pregnancy and lactation.
He XJ; Yamauchi H; Suzuki K; Ueno M; Nakayama H; Doi K
Exp Mol Pathol; 2007 Dec; 83(3):428-34. PubMed ID: 16824515
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of xenobiotics and chemical carcinogenesis.
Lang M; Pelkonen O
IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics in HIV therapy.
Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
